Other languages Mochida Pharmaceutical Co., Ltd.

Equities

4534

JP3922800002

Market Closed - Japan Exchange Other stock markets 11:30:00 02/05/2024 am IST			5-day change	1st Jan Change
3,190 ^JPY	-0.47%		+1.43%	-2.45%

25/04	Hidehiro Imatsu named president of Goldman Sachs Japan	RE
21/03	Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hidehiro Imatsu named president of Goldman Sachs Japan	25/04
Mochida Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024	05/02
Mochida Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	05/02
Mochida Pharmaceutical Co., Ltd. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 1, 2023 and Provides Dividend Guidance for the Year Ending March 31, 2024	02/11
Mochida Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	02/11
Mochida Pharmaceutical Co., Ltd. Provides Second Quarter-End and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	04/23/04
Mochida Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	04/23/04
Mochida Pharmaceutical's Fiscal Full-Year Profit Falls 37.1%	16/23/16
Mochida Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	15/23/15
Mochida Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	15/23/15
Mochida Pharmaceutical Co., Ltd. Provides Second Quarter-End and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	15/23/15
Mochida Pharmaceutical Co., Ltd. Announces Year-End Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 30, 2023	15/23/15
Mochida Pharmaceutical Co., Ltd. announces an Equity Buyback for 1,080,000 shares, representing 2.96% for ¥3,500 million.	15/23/15
Mochida Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	15/23/15
Mochida Pharmaceutical Co., Ltd. announces an Equity Buyback for 1,190,000 shares, representing 3.17% for ¥3,500 million.	01/22/01
Mochida Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	01/22/01
Idorsia schliesst erstes Halbjahr 2021 etwas besser als erwartet ab	27/21/27
Idorsia schliesst erstes Quartal 2021 besser als erwartet ab	22/21/22
Idorsia senkt 2020 Ausgaben stärker als erwartet	04/21/04
Idorsia schreibt nach neun Monaten weniger Verlust	27/20/27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Mochida Pharmaceutical Co., Ltd.

Equities

4534

JP3922800002

Other languages

Filters